NEUVOGEN Appoints Biotechnology Veteran, Mark Backer, PhD as Head of Technical Operations - read this article along with other careers information, tips and advice on BioSpace
/PRNewswire/ NEUVOGEN, an immunoncology company, announced today that Mark Backer, PhD has joined the company as Head of Technical Operations, and will be.
/PRNewswire/ A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled.
Retinoic acid signaling from Muller glia is necessary for cone photoreceptor survival in the peripheral retina and is sufficient to promote cone survival in the central retina during retinal degeneration.
Hijacking Methyl Reader Proteins for Nuclear-Specific Protein Degradation acs.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acs.org Daily Mail and Mail on Sunday newspapers.